Summary: Creative Biolabs spends long-term commitment to develop excellent-quality coxsackievirus A16 (CA16) virus-like particles (VLPs). Virus-like particles (VLPs) highly resemble the structure of authentic viruses without being infectious. As they do not contain any viral genetic materials, they have great potential to elicit a strong immune response, while will not induce any actual harms. VLPs has emerged one powerful tool in diverse fields, such as vaccines, antibody development, lipoparticle technology, delivery systems, bioimaging and cell targeting. https://www.creative-biolabs.com/coxsackievirus-a16-ca16-virus-like-particles-vlps.html
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
